Drug Development - 2/26

Entry	Author	Date	Location
Fresh Off Amira Success, Versant’s Bolzon and San Diego’s Prasit Begin Anew with Inception	Bruce V. Bigelow	11/29/11	San Diego
Rib-X Pharma Files for IPO	Arlene Weintraub	11/28/11	Boston
ScaleVP’s Mitchell: FDA’s Capriciousness Is Driving Out Life Sciences Investors	Wade Roush	11/09/11	San Francisco
The Stroke Prevention War is On: FDA Approves J&J/Bayer Contender	Arlene Weintraub	11/07/11	New York
NPS Charts Positive Results on Parathyroid Drug	Arlene Weintraub	11/07/11	New York
Xconomists of the Week: Tom Maniatis and Marc Tessier-Lavigne Lead the Charge on the New York Genome Center	Arlene Weintraub	11/03/11	New York
NPS Pharma’s Not-So-Excellent Wall Street Adventure	Arlene Weintraub	11/03/11	New York
New York Genome Center to Open in February, Supported by $125M in Public and Private Funding	Arlene Weintraub	11/02/11	New York
Cubist Says Adolor Deal Offers “Free Option on Billion-Dollar Program”	Arlene Weintraub	10/26/11	Boston
Life Sciences 2031: What about 2011?	David Sable	10/20/11	New York
Merck Fine-Tunes Biosimilars Strategy as FDA Guidelines Loom	Arlene Weintraub	10/05/11	New York
Backed by Eclectic Financiers, Acetylon Begins Trials of Cancer Drug	Arlene Weintraub	09/27/11	Boston
San Diego’s Afraxis Gets NIH Support to Develop Compound for Rare Fragile X Syndrome	Bruce V. Bigelow	09/26/11	San Diego
Latest in Stroke-Prevention Saga: FDA Panel Backs Drug From J&J and Bayer	Arlene Weintraub	09/09/11	New York
Bristol-Pfizer Team on Alert as FDA Reviews Stroke-Prevention Drug From Rivals J&J and Bayer	Arlene Weintraub	09/08/11	New York
Repligen Seeks Approval for Imaging Product While Pursuing Rare-Disease Drugs and Manufacturing Platform	Arlene Weintraub	09/01/11	Boston
Consortium Find New HIV Antibodies, Zogenix Gets Drug to Clinical End Point, TrovaGene Reclaims Technology, & More San Diego Life Sciences News	Bruce V. Bigelow	08/18/11	San Diego
Innovate or Conserve Cash? The Growing Dilemma for Biotech Firms	Aftab Jamil	08/16/11	San Francisco
Adventrx Shares Plummet, Pfizer Adds UC San Diego to its Network, New RNAi Center Opens, & More San Diego Life Sciences News	Bruce V. Bigelow	08/11/11	San Diego
Adventrx Shares Plunge After FDA Nixes Revised Application for Anti-Cancer Drug	Bruce V. Bigelow	08/10/11	San Diego
Amylin & Takeda Halt Obesity Drug Development	Bruce V. Bigelow	08/04/11	San Diego
Vertex Sales Much Bigger Than Expected, Amylin Re-Submits Exenatide, Mini VC Fund Debuts, & More San Diego Life Sciences News	Bruce V. Bigelow	08/04/11	San Diego
New York Hedge Fund Makes $378 Million Bid for Amag in Attempt to Block Poorly Received Merger	Arlene Weintraub	08/03/11	Boston
Acceleron Gets $25 Million in Partnership Deal With Celgene	Arlene Weintraub	08/03/11	Boston
Ventrus Attracts Investors With Hemorrhoid Drug and Two Other Late-Stage Drug Candidates	Arlene Weintraub	08/02/11	New York
Cerulean Shows Progress in Cancer, Tests Nano-Drug Platform in RNAi	Arlene Weintraub	07/27/11	Boston
EnVivo, Backed by Fidelity Biosciences, Tests New Weapon Against Alzheimer’s	Arlene Weintraub	07/25/11	Boston
Zogenix Strategy Unfolds as it Unveils Plans for Next Drug-and-Device Combo	Bruce V. Bigelow	07/19/11	San Diego
Encouraged by Early Work on Anti-Cancer Drug, Intellikine Hires New Head for Clinical Trials	Bruce V. Bigelow	07/18/11	San Diego
Amag Eyes Rebound, Idera Surges On Despite Merck KGaA Drop, Verastem Snags $32M, & More Boston-Area Life Sciences News	Erin Kutz	07/15/11	Boston
Page 2 of 9	« previous page · next page »

Entry

Author

Date

Location

Fresh Off Amira Success, Versant’s Bolzon and San Diego’s Prasit Begin Anew with Inception

Bruce V. Bigelow

11/29/11

San Diego

Rib-X Pharma Files for IPO

Arlene Weintraub

11/28/11

Boston